Unlock Strategic Intelligence with Fundz
Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.
Julier Medical Raises €3 Million In Seed Financing From Sofinnova Partners To Treat Patients With Acute Ischemic Stroke
Julier Medical Raises €3 Million In Seed Financing From Sofinnova Partners To Treat Patients With Acute Ischemic Stroke
01/23/23, 12:41 PM
Location
parisMoney raised
€3 million
Industry
medical device
medical
biotechnology
health care
Round Type
seed
Investors
Sofinnova, Sofinnova Partners
PARIS, FRANCE / January 23, 2023 / Julier Medical ("Julier"), a Paris-based medical device company developing an innovative solution for the removal of blood clots and post-stroke revascularization, today announced a successful €3 million seed financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan. The funds will support the development of Julier's mechanical thrombectomy device to treat patients with Acute Ischemic Stroke (AIS) until its first clinical study. This is the fifth investment by Sofinnova's medtech acceleration fund, Sofinnova MD Start III.
🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.
Company Info
Location
paris, ile de france, france
Additional Info
Julier is developing a next generation mechanical thrombectomy solution for the removal of thrombus and revascularization of patients experiencing Acute Ischemic Strokes. The core technology is derived from the work of two serial medtech entrepreneurs, Laurent Grandidier and Niall Behan.
💰 Fundz Parnter Program
Earn $50–$75 per paid seat you refer to Fundz. Get your own link in 15 seconds and start earning.
No purchase necessary. Anyone can join and start earning today.
Related people
LH
MH